Biochim Biophys Acta. 2012 Aug;1823(8):1242-51. doi: 10.1016/j.bbamcr.2012.05.023. Epub 2012 May 26.
Capacitative and non-capacitative signaling complexes in human platelets.
Berna-Erro, A., Galan, C., Dionisio, N., Gomez, L. J., Salido, G. M., Rosado, J. A.,
["Department of Physiology, University of Extremadura, Caceres, Spain."]
["Department of Physiology, University of Extremadura, Caceres, Spain."]
Discharge of the intracellular Ca(2+) stores activates Ca(2+) entry through store-operated channels (SOCs). Since the recent identification of STIM1 and STIM2, as well as the Orai1 homologs, Orai2 and Orai3, the protein complexes involved in Ca(2+) signaling needs re-evaluation in native cells. Using real time PCR combined with Western blotting we have found the expression of the three Orai isoforms, STIM1, STIM2 and different TRPCs in human platelets. Depletion of the intracellular Ca(2+) stores with thapsigargin, independently of changes in cytosolic Ca(2+) concentration, enhanced the formation of a signaling complex involving STIM1, STIM2, Orai1, Orai2 and TRPC1. Furthermore, platelet treatment with the dyacylglicerol analog 1-oleoyl-2-acetyl-sn-glycerol (OAG) resulted in specific association of Orai3 with TRPC3. Treatment of platelets with arachidonic acid enhanced the association between Orai1 and Orai3 in human platelets and overexpression of Orai1 and Orai3 in HEK293 cells increased arachidonic acid-induced Ca(2+) entry. These results indicate that Ca(2+) store depletion results in the formation of exclusive signaling complexes involving STIM proteins, as well as Orai1, Orai2 and TRPC1, but not Orai3, which seems to be involved in non-capacitative Ca(2+) influx in human platelets.
PMID: 22640869

![]() ![]() ![]() ![]() ![]() |
![]() |
Screening
![]() |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Experimental screening | Non-experimental screening | Reference | ||||||||
TRP channel construct | Interactor source | |||||||||
TRP channel | Interactor | Method | Species | Region | Species | Organ/tissue | Sample type | |||
TRPC1 |
![]() |
Orai2 | Speculation | Prediction | 22640869 | |||||
TRPC1 |
![]() |
Orai3 | Speculation | Prediction | 22640869 | |||||
TRPC1 |
![]() |
STIM2 | Speculation | Prediction | 22640869 | |||||
TRPC3 |
![]() |
STIM1 | Speculation | Prediction | 22640869 | |||||
TRPC3 |
![]() |
STIM2 | Speculation | Prediction | 22640869 | |||||
TRPC6 |
![]() |
Orai2 | Speculation | Prediction | 22640869 | |||||
TRPC6 |
![]() |
Orai3 | Speculation | Prediction | 22640869 |
(
:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)

![]() ![]() ![]() ![]() ![]() |
![]() |
Validation: In vivo validation
![]() |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Assay with endogenous proteins | Assay with overexpressed proteins | Reference | ||||||||
Cell or tissue | Cell or tissue | TRP channel construct | Interactor construct | |||||||
TRP channel | Interactor | Method | Species | Region | Species | Region | ||||
TRPC1 |
![]() |
Orai2 | Co-immunoprecipitation | Human platelets | 22640869 | |||||
TRPC1 |
![]() |
Orai3 | Co-immunoprecipitation | Human platelets | 22640869 | |||||
TRPC1 |
![]() |
STIM2 | Co-immunoprecipitation | Human platelets | 22640869 | |||||
TRPC3 |
![]() |
Orai2 | Co-immunoprecipitation | Human platelets | 22640869 | |||||
TRPC3 |
![]() |
Orai3 | Co-immunoprecipitation | Human platelets | 22640869 | |||||
TRPC3 |
![]() |
STIM1 | Co-immunoprecipitation | Human platelets | 22640869 | |||||
TRPC3 |
![]() |
STIM2 | Co-immunoprecipitation | Human platelets | 22640869 | |||||
TRPC6 |
![]() |
Orai2 | Co-immunoprecipitation | Human platelets | 22640869 | |||||
TRPC6 |
![]() |
Orai3 | Co-immunoprecipitation | Human platelets | 22640869 |
(
:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
